Detalhe da pesquisa
1.
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
Gynecol Oncol
; 163(1): 72-78, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34412908
2.
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Clin Cancer Res
; 26(20): 5411-5423, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32554541
3.
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
Eur J Cancer
; 76: 52-59, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28273485
4.
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nat Genet
; 49(5): 680-691, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28346442
5.
First-line PARP inhibition in ovarian cancer - standard of care for all?
Nat Rev Clin Oncol
; 17(3): 136-137, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32051558